Rapamycin clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Rapamycin Clinical Uses: Immunosuppression, Cardiovascular, and Anti-Proliferative Applications
Rapamycin (sirolimus) is widely recognized for its immunosuppressive properties, making it a key drug in preventing organ transplant rejection. It is also used to prevent in-stent restenosis and vascular graft stenosis in patients with coronary artery disease due to its anti-proliferative effects on vascular smooth muscle cells, helping to reduce the risk of vessel re-narrowing after procedures like angioplasty 136.
Rapamycin in Cancer Prevention and Therapy
Rapamycin and its analogs (rapalogs) are used clinically as anti-cancer agents. They work by slowing cell proliferation and tumor progression, and have shown effectiveness in preventing cancer in organ transplant patients and in various animal models. Rapamycin targets the mTOR pathway and also directly inhibits STAT3, a protein involved in cancer cell growth, further supporting its use in cancer therapy 456.
Rapamycin for Age-Related Diseases and Longevity
Rapamycin has been shown to extend lifespan and delay age-related diseases in animal studies. There is growing interest in its potential as a geroprotective agent in humans, with ongoing clinical trials exploring its safety and effectiveness for promoting healthy aging and preventing age-related conditions. Some physicians are already prescribing rapamycin off-label to promote healthspan, with initial evidence suggesting it can be used safely in healthy adults 269.
Rapamycin in Neurological and Neurodegenerative Disorders
Preclinical studies indicate that rapamycin may benefit neurodegenerative diseases by enhancing autophagy and reducing neuroinflammation. It is being tested in clinical trials for amyotrophic lateral sclerosis (ALS), where it aims to increase regulatory T cells and slow disease progression. There is also strong support for clinical trials of rapamycin in Alzheimer’s disease, based on its positive effects in animal models 710.
Rapamycin in Ischemic and Inflammatory Brain Conditions
Rapamycin has shown promise in reducing neuronal injury and modulating microglial activation after cerebral ischemia (stroke) in animal studies. It helps create a more beneficial immune environment in the brain, suggesting potential as a treatment for ischemic cerebrovascular diseases .
Conclusion
Rapamycin is clinically used for immunosuppression in organ transplantation, prevention of vascular restenosis, and as an anti-cancer agent. It is being actively explored for its potential in cancer prevention, age-related diseases, neurodegenerative disorders, and brain injury. Ongoing and future clinical trials will further clarify its broader therapeutic applications and optimal use in human health 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic